United Therapeutics Corp. (UTHR)
549.16
+16.38
(+3.07%)
USD |
NASDAQ |
Oct 09, 16:00
550.98
+1.82
(+0.33%)
After-Hours: 20:00
United Therapeutics Free Cash Flow (Quarterly) : 202.20M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 202.20M |
| March 31, 2026 | 362.50M |
| December 31, 2025 | 173.30M |
| September 30, 2025 | 346.10M |
| June 30, 2025 | 129.50M |
| March 31, 2025 | 386.30M |
| December 31, 2024 | 254.50M |
| September 30, 2024 | 298.00M |
| June 30, 2024 | 187.10M |
| March 31, 2024 | 338.30M |
| December 31, 2023 | 74.70M |
| September 30, 2023 | 280.50M |
| June 30, 2023 | 61.60M |
| March 31, 2023 | 330.80M |
| December 31, 2022 | 81.20M |
| September 30, 2022 | 189.80M |
| June 30, 2022 | 110.00M |
| March 31, 2022 | 275.20M |
| December 31, 2021 | 104.00M |
| September 30, 2021 | 162.30M |
| June 30, 2021 | 131.90M |
| March 31, 2021 | 79.20M |
| December 31, 2020 | 112.20M |
| September 30, 2020 | 235.10M |
| June 30, 2020 | 145.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 201.60M |
| December 31, 2019 | 77.80M |
| September 30, 2019 | 171.80M |
| June 30, 2019 | 112.60M |
| March 31, 2019 | -652.50M |
| December 31, 2018 | 66.60M |
| September 30, 2018 | 163.00M |
| June 30, 2018 | 126.30M |
| March 31, 2018 | 238.10M |
| December 31, 2017 | -113.60M |
| September 30, 2017 | 236.50M |
| June 30, 2017 | 49.80M |
| March 31, 2017 | 215.20M |
| December 31, 2016 | 148.70M |
| September 30, 2016 | 219.60M |
| June 30, 2016 | 115.30M |
| March 31, 2016 | 116.80M |
| December 31, 2015 | -6.021M |
| September 30, 2015 | 196.87M |
| June 30, 2015 | 37.15M |
| March 31, 2015 | 104.97M |
| December 31, 2014 | 88.32M |
| September 30, 2014 | 194.89M |
| June 30, 2014 | -67.32M |
| March 31, 2014 | 91.92M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Liquidia Corp. | 69.01M |
| MannKind Corp. | -23.71M |
| Insmed, Inc. | -95.09M |
| Alnylam Pharmaceuticals, Inc. | 292.04M |
| Savara, Inc. | -29.97M |